Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 17320513646 |
| E-mail: | mike@molcoo.com |
| QQ: | 3001071511 |
| Skype: | Chat Now! |
| Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
|
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
|
| Product Name | MF | CAS | Details |
|---|
| 183320-12-9 | C20H20ClN3O4 | 183320-12-9 | Details |
| 749927-69-3 | C8H7BrFNO | 749927-69-3 | Details |
| pioglitazone EP impurity D | C21H26N2O4S | 868754-41-0 | Details |
| 4504-96-5 | C18H20ClNO | 4504-96-5 | Details |
| 404874-94-8 | C20H20FNO4 | 404874-94-8 | Details |
| 25127-31-5 | C19H22ClNO | 25127-31-5 | Details |
| 212838-70-5 | C9H11Cl2NO2 | 212838-70-5 | Details |
| Oxacillin EP Impurity D | C18H21N3O4S | 1642559-63-4 | Details |
| Ertapenem Dimer | C44H50N6O14S2 | 1199797-42-6 | Details |
| 86217-38-1 | C9H9NO2 | 86217-38-1 | Details |
| Carbidopa EP Impurity H | C11H16N2O4 | 1361017-74-4 | Details |
| olmesartan medoxomil impurity 74 | C25H28N6O | 133690-91-2 | Details |
| Gadobutrol Impurity 30 | C20H40N4O4 | 507475-91-4 | Details |
| bumetanide impurity 17 | C21H28N2O5S | 28469-01-4 | Details |
| 183322-18-1 | C14H17ClN2O4 | 183322-18-1 | Details |
| Ramelteon Impurity 11 | C19H27N3O2 | 547724-14-1 | Details |
| N-Nitroso Propranolol | 84418-35-9 | Details |
| 22889-78-7 | C5H4Cl2N2 | 22889-78-7 | Details |
| 358629-47-7 | C8H12N2O2 | 358629-47-7 | Details |
| 503155-67-7 | C46H45N7O2 | 503155-67-7 | Details |
| 1243391-44-7 | C11H12O4 | 1243391-44-7 | Details |
| Carbidopa EP Impurity J | C10H13BrN2O4 | 43197-33-7 | Details |
| Irbesartan Impurity 16 | C14H11N7 | 152708-24-2 | Details |
| dapoxetine impurity 3 (hydrochloride) | C21H24ClNO | 156453-51-9 | Details |
| 29489-04-1 | C17H16BrNO3S | 29489-04-1 | Details |
| Pyronaridine Impurity 9 | C12H5Cl3N2 | 81935-64-0 | Details |
| 183322-20-5 | C13H14Cl2N2O3 | 183322-20-5 | Details |
| 131926-99-3 | C16H14F3N3O3S | 131926-99-3 | Details |
| 4-O-Methyldopa Impurity | C11H15NO4 | 1269789-01-6 | Details |
| Gabapentin Impurity 28 | C10H13NO2 | 55568-06-4 | Details |
| trans-Bilastine N-Oxide | C28H37N3O4 | 1934257-94-9 | Details |
| 197291-75-1 | C18H20FN3O4 | 197291-75-1 | Details |
| dydrogesterone EP impurity A | C20H25NO3 | 86153-39-1 | Details |
| Galantamine EP Impurity D | C17H19NO2 | 664995-65-7 | Details |
| dulaglutide impurity 73 | C21H25ClO6 | 2133407-75-5 | Details |
| 54705-42-9 | C7H13NO2 | 54705-42-9 | Details |
| Fluvoxamine EP Impurity E | C15H22F2N2O2 | 1217214-94-2 | Details |
| Bromocriptine Impurity | C32H40BrN5O5 | 82773-21-5 | Details |
| 60079-22-3 | C8H12N2O7 | 60079-22-3 | Details |
| 58471-53-7 | C8H12N2O7 | 58471-53-7 | Details |
| 110548-07-7 | C13H9F2NO4 | 110548-07-7 | Details |
| dulaglutide impurity 67 | C22H27ClO7 | 1528636-07-8 | Details |
| 142618-93-7 | C7H13NO2 | 142618-93-7 | Details |
| Valaciclovir EP Impurity P | C27H40N12O8 | 1356019-51-6 | Details |
| 1510820-22-0 | C24H23F2NO2 | 1510820-22-0 | Details |
| 178554-19-3 | C27H31N7O2 | 178554-19-3 | Details |
| 158151-92-9 | C22H29ClN2O5 | 158151-92-9 | Details |
| Pyronaridine Impurity 8 | C13H18N2O2 | 13886-02-7 | Details |
| 6836-19-7 | C11H12O2 | 6836-19-7 | Details |
| 108139-78-2 | C19H18N4O6 | 108139-78-2 | Details |
| dulaglutide impurity 94 | C6H10O6 | 32746-79-5 | Details |
| 5,6-trans-Bimatoprost | C25H37NO4 | 1163135-95-2 | Details |
| 162401-30-1 | C14H8Cl2F4N2O3 | 162401-30-1 | Details |
| 1312937-41-9 | C15H20N2O5 | 1312937-41-9 | Details |
| Landiolol (Hydrochloride) | C25H40ClN3O8 | 144481-98-1 | Details |
| 179232-29-2 | C8H6BrFO2 | 179232-29-2 | Details |
| pioglitazone EP impurity A | C19H20N2O4S | 625853-74-9 | Details |
| 1323485-71-7 | C13H16N2O4S | 1323485-71-7 | Details |
| 945553-91-3 | C24H25ClFN5O3 | 945553-91-3 | Details |
| 77252-87-0 | C17H21NO3 | 77252-87-0 | Details |
| 618385-10-7 | C29H33FN2O4 | 618385-10-7 | Details |
| Ampicillin Impurity 19 | C48H57N9O12S3 | 114977-84-3 | Details |
| Flucytosine | C4H4FN3O | 2022-85-7 | Details |
| 32510-61-5 | C13H14N6O6S | 32510-61-5 | Details |
| N-Nitroso Desmethyl Levofloxacin | C17H17FN4O5 | 1152314-62-9 | Details |
| 168626-74-2 | C20H15NO3 | 168626-74-2 | Details |
| 314771-76-1 | C18H16ClFN4O2 | 314771-76-1 | Details |
| 475271-62-6 | C16H14Cl2N2O3 | 475271-62-6 | Details |
| 380894-77-9 | C16H19FNO3P | 380894-77-9 | Details |
| 1612153-32-8 | C20H20FNO4 | 1612153-32-8 | Details |
| 528565-93-7 | C20H20FNO4 | 528565-93-7 | Details |
| Febuxostat Impurity 29 | C16H18N2O4S | 1350352-70-3 | Details |
| 331258-31-2 | C23H32ClN3O6 | 331258-31-2 | Details |
| 82419-52-1 | C17H18FN3O4 | 82419-52-1 | Details |
| 102029-44-7 | C10H11NO2 | 102029-44-7 | Details |
| Olaparib Impurity 44 | C7H3Br2FO | 477535-39-0 | Details |
| Metoclopramide Impurity 22 | C10H13ClN2O2 | 476614-80-9 | Details |
| 161696-76-0 | C16H18N4S | 161696-76-0 | Details |
| Olodaterol Impurity 18 | C22H26N2O5 | 2727170-18-3 | Details |
| 3153-36-4 | C6H11ClO2 | 3153-36-4 | Details |
| 183320-15-2 | C23H23N3O5 | 183320-15-2 | Details |
| 142-08-5 | C5H5NO | 142-08-5 | Details |
| 179688-26-7 | C15H21NO8 | 179688-26-7 | Details |
| 318237-73-9 | C12H13N3 | 318237-73-9 | Details |
| 950596-58-4 | C13H18N2O4 | 950596-58-4 | Details |
| 761404-85-7 | C43H40N6O3 | 761404-85-7 | Details |
| baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
| 861453-16-9 | C15H21N3O6 | 861453-16-9 | Details |
| 117620-84-5 | C13H10FNO4 | 117620-84-5 | Details |
| 666816-91-7 | C20H28N6O4 | 666816-91-7 | Details |
| Carbazochrome Sodium Sulfonate Impurity 14 | C10H12N4O5S | 2666934-59-2 | Details |
| 90319-52-1 | C9H9NO2 | 90319-52-1 | Details |
| 717917-14-1 | C19H19N3O2S | 717917-14-1 | Details |
| 183322-17-0 | C15H24ClNO6 | 183322-17-0 | Details |
| Flurbiprofen EP Impurity B | C18H17FO4 | 1797883-74-9 | Details |
| 1391054-15-1 | C26H32O4 | 1391054-15-1 | Details |
| 1070876-09-3 | C28H26N6S2 | 1070876-09-3 | Details |
| 431058-46-7 | C15H14FNO4 | 431058-46-7 | Details |
| Clindamycin Phosphate α Isomer | C18H34ClN2O8PS | 1800297-62-4 | Details |
| Olodaterol Impurity 17 | C21H26N2O5 | 868049-50-7 | Details |
| Product Total： Product Page： | ||||
| 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 | ||||